Solara Active Pharma Sciences Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 3,108

Employees

  • Stock Symbol
  • 541540

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $6.74
  • (As of Friday Closing)

Solara Active Pharma Sciences General Information

Description

Solara Active Pharma Sciences Ltd is an Active Pharmaceutical Ingredients company engaged in the development and manufacture of APIs and providing CDMO services to pharmaceutical companies. The Company operates through six multi-product manufacturing facilities and is engaged in the manufacture and sale of Active Pharma Ingredients. Its products include Anthelmintic, Anticonvulsant, Loop Diuretic, Anxiolytic, Antihistamine, Antipsychotic, Calcimimetic Agent, Antigout Agent, Anti-hyperlipidemic, and others. The Company generates maximum revenue from Asia Pacific.

Contact Information

Formerly Known As
SSL Pharma Sciences
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 3rd & 4th Floor, Batra Centre, No.28, Sardar Patel Road
  • Guindy
  • Chennai, Tamilnadu 600032
  • India
+91 044
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • 3rd & 4th Floor, Batra Centre, No.28, Sardar Patel Road
  • Guindy
  • Chennai, Tamilnadu 600032
  • India
+91 044

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Solara Active Pharma Sciences Stock Performance

As of 20-Nov-2026, Solara Active Pharma Sciences’s stock price is $6.74. Its current market cap is $325M with 48.3M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.74 $6.84 $4.46 - $8.08 $325M 48.3M 22.7K $0.08

Solara Active Pharma Sciences Financials Summary

As of 30-Sep-2026, Solara Active Pharma Sciences has a trailing 12-month revenue of $166M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 430,346 263,500 348,469 276,772
Revenue 165,579 150,531 146,819 149,590
EBITDA 24,951 18,985 23,912 (34,727)
Net Income 3,984 (839) 64 (68,537)
Total Assets 255,502 247,221 260,914 281,912
Total Debt 61,565 72,765 93,066 121,292
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Solara Active Pharma Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Solara Active Pharma Sciences‘s full profile, request access.

Request a free trial

Solara Active Pharma Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Solara Active Pharma Sciences Ltd is an Active Pharmaceutical Ingredients company engaged in the development and manufac
Biotechnology
Chennai, India
3,108 As of 2026

Mumbai, India
 

Hyderabad, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Solara Active Pharma Sciences Competitors (20)

One of Solara Active Pharma Sciences’s 20 competitors is Aarti Drugs, a Corporation company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aarti Drugs Corporation Mumbai, India
Neuland Laboratories Corporation Hyderabad, India
Jubilant Pharmova Corporation Noida, India
Evonile Pharma Private Equity-Backed Mumbai, India
Divi's Laboratories Corporation Hyderabad, India
You’re viewing 5 of 20 competitors. Get the full list »

Solara Active Pharma Sciences Patents

Solara Active Pharma Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020039449-A1 An improved process for the preparation of obeticholic acid and intermediates used in the process thereof Inactive 24-Aug-2018
US-20210261599-A1 Process for the preparation of obeticholic acid and intermediates used in the process thereof Inactive 24-Aug-2018
US-11142603-B2 Process for preparation of patiromer Inactive 16-May-2018
US-20190352442-A1 Process for preparation of patiromer Active 16-May-2018
WO-2019220450-A1 Process for preparation of patiromer Inactive 16-May-2018 C08F220/22
To view Solara Active Pharma Sciences’s complete patent history, request access »

Solara Active Pharma Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Solara Active Pharma Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Solara Active Pharma Sciences‘s full profile, request access.

Request a free trial

Solara Active Pharma Sciences Investments & Acquisitions (3)

Solara Active Pharma Sciences’s most recent deal was a Merger/Acquisition with Aurore Life Sciences. The deal was made on 01-Apr-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aurore Life Sciences 01-Apr-2021 Merger/Acquisition Pharmaceuticals
SeQuent Penems 03-Feb-2021 Secondary Transaction - Private Other Pharmaceuticals and Biotechnology
Strides Chemicals 01-Sep-2018 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Solara Active Pharma Sciences’s complete investments and acquisitions history, request access »

Solara Active Pharma Sciences ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Solara Active Pharma Sciences’s complete esg history, request access »

Solara Active Pharma Sciences Exits (1)

Solara Active Pharma Sciences’s most recent exit was on 03-Feb-2021 from SeQuent Penems. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
SeQuent Penems 03-Feb-2021 Completed
To view Solara Active Pharma Sciences’s complete exits history, request access »

Solara Active Pharma Sciences Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Aurore Life Sciences Hyderabad, India 2017

Solara Active Pharma Sciences FAQs

  • When was Solara Active Pharma Sciences founded?

    Solara Active Pharma Sciences was founded in 2017.

  • Where is Solara Active Pharma Sciences headquartered?

    Solara Active Pharma Sciences is headquartered in Chennai, India.

  • What is the size of Solara Active Pharma Sciences?

    Solara Active Pharma Sciences has 3,108 total employees.

  • What industry is Solara Active Pharma Sciences in?

    Solara Active Pharma Sciences’s primary industry is Biotechnology.

  • Is Solara Active Pharma Sciences a private or public company?

    Solara Active Pharma Sciences is a Public company.

  • What is Solara Active Pharma Sciences’s stock symbol?

    The ticker symbol for Solara Active Pharma Sciences is 541540.

  • What is the current stock price of Solara Active Pharma Sciences?

    As of 20-Nov-2026 the stock price of Solara Active Pharma Sciences is $6.74.

  • What is the current market cap of Solara Active Pharma Sciences?

    The current market capitalization of Solara Active Pharma Sciences is $325M.

  • What is Solara Active Pharma Sciences’s current revenue?

    The trailing twelve month revenue for Solara Active Pharma Sciences is $166M.

  • Who are Solara Active Pharma Sciences’s competitors?

    Aarti Drugs, Neuland Laboratories, Jubilant Pharmova, Evonile Pharma, and Divi's Laboratories are some of the 20 competitors of Solara Active Pharma Sciences.

  • What is Solara Active Pharma Sciences’s annual earnings per share (EPS)?

    Solara Active Pharma Sciences’s EPS for 12 months was $0.08.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process